Tenet Healthcare
TENET HEALTHCARE CORP
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$21.3B
Operating marginCalculated
16.5%
Net assets to total assetsCalculated
14.2%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★☆position among all companies
16.5%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
2.3%
Capital efficiency
Could not be retrieved
Revenue and profit
Performance, financial position and capital allocation
Tenet Healthcare
Recent performance trends
Tenet Healthcare
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$19.5 billion | US$19.2 billion | US$20.6 billion | US$20.7 billion | US$21.3 billion |
| Operating income | US$2.9 billion | US$2.3 billion | US$2.5 billion | US$6.0 billion | US$3.5 billion |
| Total assets | US$27.6 billion | US$27.2 billion | US$28.3 billion | US$28.9 billion | US$29.7 billion |
| Shareholders' equity | US$1.0 billion | US$1.1 billion | US$1.6 billion | US$4.2 billion | US$4.2 billion |
| Net cash provided by (used in) operating activities | US$1.6 billion | US$1.1 billion | US$2.4 billion | US$2.0 billion | US$3.5 billion |
| Net cash provided by (used in) investing activities | US$-0.7 billion | US$-0.8 billion | US$-1.0 billion | US$3.4 billion | US$-1.3 billion |
| Net cash provided by (used in) financing activities | US$-0.9 billion | US$-1.8 billion | US$-1.0 billion | US$-3.7 billion | US$-2.4 billion |
| Cash and cash equivalents | US$2.4 billion | US$0.9 billion | US$1.2 billion | US$3.0 billion | US$2.9 billion |
Revenue scale in the same industry
Tenet Healthcare
Health services: 20 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 HCA Healthcare US$75.6B
- 2 Tenet HealthcareThis company US$21.3B
- 3 Universal Health Services US$17.4B
- 4 Labcorp Holdings US$14.0B
- … 16 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$1.0 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$2.9 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-2.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-1.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$3.5 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.9 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$6.0 billion | Consolidated | Disclosed |
| Non-controlling interests | US$1.8 billion | Consolidated | Disclosed |
| Net assets | US$4.2 billion | Consolidated | Disclosed |
| Net sales | US$21.3 billion | Consolidated | Disclosed |
| Operating income | US$3.5 billion | Consolidated | Disclosed |
| Total assets | US$29.7 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$1.4 billion | Consolidated | Disclosed |
| Operating margin | 16.5% | Consolidated | Calculated |
| Net assets to total assets | 14.2% | Consolidated | Calculated |
| Net margin | Cannot be calculated | Not applicable | Not calculated (no net income in this year's 10-K) |
| Return on equity | Cannot be calculated | Not applicable | Not calculated (no net income in this year's 10-K) |